Spitfire Pharma Overview
- Year Founded
-
2011
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$80M
Spitfire Pharma General Information
Description
Developer of peptide drugs designed for the treatment of diabetes and obesity. The company's drugs offer drug development and research services for the development of SP-1373 Glucagon receptor co-agonist to treat non-alcoholic steatohepatitis for biopsy-proven, a diet-induced mouse model of NASH, enabling doctors to improve the pharmaceutical properties of peptide drugs.
Contact Information
Corporate Office
- 400 Oyster Point Boulevard
- Suite 202
- South San Francisco, CA 94080
- United States
Corporate Office
- 400 Oyster Point Boulevard
- Suite 202
- South San Francisco, CA 94080
- United States
Spitfire Pharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Merger/Acquisition | 08-Jul-2019 | $80M | Completed | Generating Revenue | ||
| 1. Early Stage VC | 11-Jan-2013 | Completed | Startup |
Spitfire Pharma Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Spitfire Pharma Former Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Presidio Partners | Venture Capital | Minority |
Spitfire Pharma FAQs
-
When was Spitfire Pharma founded?
Spitfire Pharma was founded in 2011.
-
Where is Spitfire Pharma headquartered?
Spitfire Pharma is headquartered in South San Francisco, CA.
-
What industry is Spitfire Pharma in?
Spitfire Pharma’s primary industry is Drug Discovery.
-
Is Spitfire Pharma a private or public company?
Spitfire Pharma is a Private company.
-
What is the current valuation of Spitfire Pharma?
The current valuation of Spitfire Pharma is .
-
What is Spitfire Pharma’s current revenue?
The current revenue for Spitfire Pharma is .
-
How much funding has Spitfire Pharma raised over time?
Spitfire Pharma has raised $500K.
-
Who are Spitfire Pharma’s investors?
Presidio Partners has invested in Spitfire Pharma.
-
When was Spitfire Pharma acquired?
Spitfire Pharma was acquired on 08-Jul-2019.
-
Who acquired Spitfire Pharma?
Spitfire Pharma was acquired by Altimmune.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
